Drug Information

Drug General Information
Drug ID
D08IDB
Former ID
DIB012063
Drug Name
HuA33
Synonyms
CDP-833; A33-radionuclides, American Cyanamid; A33-radionuclides, Celltech; HuA33, Ludwig Institute for Cancer Research/Life Science Pharmaceuticals
Drug Type
Antibody
Indication Colorectal cancer [ICD9: 153, 154; ICD10:C18-C21] Phase 1 [521702], [527624]
Company
UCB Celltech
CAS Number
CAS 339183-89-0
Target and Pathway
Target(s) Cell surface A33 antigen Target Info [531562]
References
Ref 521702ClinicalTrials.gov (NCT00199797) Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal Cancer. U.S. National Institutes of Health.
Ref 527624Phase I trial of 131I-huA33 in patients with advanced colorectal carcinoma. Clin Cancer Res. 2005 Jul 1;11(13):4818-26.
Ref 531562(124)I-huA33 antibody PET of colorectal cancer. J Nucl Med. 2011 Aug;52(8):1173-80.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.